![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Enquest Plc | LSE:ENQ | London | Ordinary Share | GB00B635TG28 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.44 | -3.35% | 12.70 | 12.68 | 12.72 | 13.46 | 12.68 | 13.46 | 983,246 | 13:01:31 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Offices-holdng Companies,nec | 1.58B | -30.83M | -0.0163 | -7.84 | 249M |
FOR IMMEDIATE RELEASE 8 July 2024
ENQUEST PLC ("EnQuest" or "the Company")
TRANSACTIONS IN OWN SHARES
EnQuest PLC (the "Company") announces that, on 5 July 2024, it purchased the following number of its ordinary shares of 5 pence each (the "Ordinary Shares") through Merrill Lynch International ("Merrill Lynch"). Such purchase was effected pursuant to the instructions issued by the Company in accordance with the share repurchase arrangements entered into with Merrill Lynch, as announced on 29 April 2024 (the "Programme").
Aggregated information of Ordinary Shares purchased on 5 July 2024 according to each trading venue:
Venue |
Weighted average price paid per share (GBp) |
Aggregate number of shares purchased |
Lowest price paid per share (GBp) |
Highest price paid per share (GBp) |
London Stock Exchange |
13.36 |
245,404 |
13.26 |
13.56 |
Chi-X (CXE) |
13.40 |
19,093 |
13.30 |
13.60 |
BATS (BXE) |
13.33 |
17,325 |
13.30 |
13.38 |
Turquoise |
13.34 |
131 |
13.34 |
13.34 |
Total (all venues) |
13.36 |
281,953 |
13.26 |
13.60 |
Since 29 April 2024, the Company has purchased 15,360,907 Ordinary Shares to be held in Treasury at a cost (including dealing and associated costs) of £2,238,685.66.
It is intended that the first 25 million Ordinary Shares purchased under the Programme will be held in Treasury for issue in due course to the Company's Employee Benefit Trust. To the extent permitted by law, and after the initial 25 million Ordinary Shares are purchased, all additional Ordinary Shares purchased under the Programme will be cancelled.
Following the above transaction, there will be 15,360,907 Ordinary Shares in Treasury and 1,900,563,432 Ordinary Shares in issue (excluding Treasury shares). The total voting rights in the Company will accordingly be 1,900,563,432. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.
A full breakdown of the individual trades made by Merrill Lynch on behalf of the Company as part of the share repurchase programme is attached to this document.
Attachment: http://www.rns-pdf.londonstockexchange.com/rns/4005V_1-2024-7-6.pdf
LEI: 2138008LJU6WFQWOXJ73
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
Enquiries:
EnQuest PLC +44 (0)20 7925 4900
Kate Christ, Company Secretary
1 Year Enquest Chart |
1 Month Enquest Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions